Form 10-K
Organization and Summary of Accounting Policies Revenues, page F-10 1. We note your disclosures that the transaction price for patient service revenues is based on gross charges net of estimated contractual adjustments and implicit price concessions. We further note your disclosure that contractual allowances are recorded at the time of payment for surgical hospitals and the time of billing for ASCs.Rest of the question
Explain what you mean by contractual adjustments versus contractual allowances and the specific reference to the authoritative literature that supports the timing for recognizing contractual allowances. 9. Income Taxes, page F-26 We note that the valuation allowance against deferred tax assets increased during fiscal year 2024 by $134.6 million, of which $115.4 million is disclosed in the effective tax rate reconciliation as a change in federal valuation allowance, which significantly exceeds the amounts recognized during the two previous fiscal years. Please provide a comprehensive explanation here or within MD&A that provides investors with an understanding of the specific facts and circumstances that led to the 2. significant increase in the valuation allowance. 14. Segment Reporting, page F-31 3. Please tell us whether you believe equity in earnings of unconsolidated affiliates and net income attributable to non-controlling interests represent significant segment expenses determined in accordance with ASC 280-10-50-26A. If so, please provide us with an explanation as to why each line item is a significant segment expense. Alternatively, if these amounts are other segment items as addressed in ASC 280-1050-26B, it appears that these amounts should be aggregated with the other segment expense, net line item into one other segment items line item. Please correspondingly provide a qualitative description of the composition of other segment items in accordance with ASC 280-10-50-26B. 4. With regards to the Corporate and other unallocated expenses in your reconciliation of Adjusted Surgical Facilities EBITDA to consolidated income before income taxes, please revise this presentation to separately disclose revenue and expenses from other business activities that are not considered reportable segments in an “all other” category in accordance with ASC 280-10-50-15 and separately identify and describe all significant reconciling items in accordance with ASC 280-10-50-31. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
The Company respectfully acknowledges the Staff’s comment and, in response to the Staff’s comment, confirms to the Staff that the terms “contractual adjustments” and “contractual allowances” are used interchangeably by the Company and have the same meaning. We determine the transaction price in accordance with ASC 606, Revenue from Contracts with Customers. Our disclosure was referring to the timing of when contractual adjustments are recorded in our patient accounting systems.Read in the replyRest of the answer
However, all revenue transactions are recognized net of estimated contractual adjustments at the time that performance obligations are satisfied, which is generally at the time of service. The Company will revise any discussion of the transaction price in future filings consistent with the following:
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and implicit price concessions. The Company estimates its contractual adjustments and implicit price concessions based on contractual agreements, its discount policies and historical experience of cash collections and historical write-offs. The estimated contractual adjustments are recognized at the time of services being performed, with ASCs typically based on contractual agreements and surgical hospitals typically based on historical experience of cash collections and write-offs. Changes in estimated contractual adjustments are recorded in the period of change, with final adjustments, if any, typically at the time of payment.
9. Income Taxes, page F-26
Income Taxes, page F-26 1. We note your response to comment 2. With reference to your consolidated statements of operations, please help us better understand how you determined that you were in a cumulative 3-year pre-tax income position as of December 31, 2023 but a pre-tax loss position as of December 31, 2024.Rest of the question
Also confirm that you will provide expanded disclosures to communicate to investors the facts and circumstances for the periods presented that support your accounting in future filings.
The Company respectfully acknowledges the Staff’s comment and, in response to the Staff’s comment, provides the table below outlining our calculation of the cumulative 3-year pre-tax income position of $14.6 million as of December 31, 2023 (dollars in millions):Read in the reply
2021 2022 2023 Total
Income before income taxes $ 81.2 $ 110.3 $ 135.0 $ 326.5
Less: Net income attributable to non-controlling interests (141.6) (141.6) (147.2) (430.4)
Other comprehensive income (loss) 29.5 107.7 (18.7) 118.5
Total $ (30.9) $ 76.4 $ (30.9) $ 14.6
The table below outlines our calculation of the cumulativeRest of the answer
3-year pre-tax loss position of $40.7 million as of December 31, 2024 (dollars in millions):
2022 2023 2024 Total
Income before income taxes $ 110.3 $ 135.0 $ 147.1 $ 392.4
Less: Net income attributable to non-controlling interests (141.6) (147.2) (180.6) (469.4)
Other comprehensive income (loss) 107.7 (18.7) (52.7) 36.3
Total $ 76.4 $ (30.9) $ (86.2) $ (40.7)
The Company confirms to the SEC that it will provide expanded disclosures to communicate to investors the facts and circumstances for the periods presented to support our accounting in future filings.
Also in this review: closing letter, 2025-08-07